Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment
Tokyo and Salt Lake City, Indianapolis, Mar 25, 2022 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One in 10…Continue Reading